Cilnidipine is a calcium channel blocker compound used as an active pharmaceutical ingredient. It is notably approved for use in Japan, China, India, Nepal, and Korea for the management of hypertension.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 132203-70-4
Pranidipine
calcium channel blocker antihypertensive agent
2-(Dimethylamino)ethanethiol hydrochloride
pharmaceutical raw material
Olanzapin
active pharmaceutical ingredient
Tulobuterol-d9 Hydrochloride
research compound
6-methyl-2-ethyl-3-hydroxypyridine hydrochloride
active pharmaceutical ingredient
3-O-(2-methoxyethyl) 5-O-[(E)-3-phenylprop-2-enyl] 2,6-dimethyl-4-(3-nitrosophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
Nitrosamine impurity reference standard
3-O-(2-methoxyethyl) 5-O-[(E)-3-phenylprop-2-enyl] 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
KJEBULYHNRNJTE-DHZHZOJOSA-N
CC1=C(C(C(=C(N1)C)C(=O)OC/C=C/C2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OCCOC